1. | whackvet | |
2. | dmunz | |
3. | 25omnihow | |
4. | tcl2015 | |
5. | paul0g7G |
1. | whackvet | |
2. | dmunz | |
3. | 25omnihow | |
4. | tcl2015 | |
5. | paul0g7G |
1. | tcl2015 10/02/2017 Is he involved with GS? |
2. | 25omnihow 10/14/2017 Nice chart setup |
3. | dmunz 02/08/2018 Aurinia Pharmaceuticals Inc (AUPH) Is an Attractive Opportunity with 75% Upside |
4. | paul0g7G 10/16/2017 Would love to see $8 tomorrow, those numbers are way high |
5. | 25omnihow 10/15/2017 Anyone see this BO calc? |
6. | paul0g7G 03/15/2018 Beats EPS loss estimates by $0.10 |
7. | whackvet 10/16/2017 Combine a disease with a huge unmet need and no approved treatments with a drug that could be the most effective ever at treating the disease, and you have the recipe for a biopharmaceutical success s |
8. | 25omnihow 10/03/2017 Why Aurinia Pharmaceuticals Could Be a Gold Mine for Growth Investors |
9. | dmunz 02/08/2018 RBC Capital initiates as an outperform, $9PT |
10. | tcl2015 10/14/2017 On target for 30%. At this rate, we hit $8 this week. |